Capital Investment Counsel (Colorado)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Capital Investment Counsel (Colorado)'s AMGN Position: Q2 2026 in Review
Capital Investment Counsel (Colorado) increased its Amgen (AMGN) stake by 1.9% in Q2 2026, buying an estimated $126K and bringing the position to 20,071 shares worth $7.27M. The position accounts for 0.9% of the portfolio, ranked #46.
Capital Investment Counsel (Colorado) first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 1,709 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Capital Investment Counsel (Colorado) held 20,071 shares of Amgen worth $7.27M as of Q2 2026.
- Capital Investment Counsel (Colorado) bought 369 Amgen shares in Q2 2026, an estimated $126K.
- Amgen made up 0.9% of Capital Investment Counsel (Colorado)'s portfolio in Q2 2026, its #46 holding.
- Capital Investment Counsel (Colorado) first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- 1,709 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Capital Investment Counsel (Colorado)'s 13F filing for Q2 2026, filed 15 Jul 2026.